Ginkgo Bioworks Holdings (DNA) Change in Account Payables (2020 - 2023)

Ginkgo Bioworks Holdings (DNA) has 4 years of Change in Account Payables data on file, last reported at -$6.7 million in Q2 2023.

• For the quarter ending Q2 2023, Change in Account Payables rose 57.14% year-over-year to -$6.7 million; the trailing twelve-month figure through Jun 2023 stood at -$18.5 million (down 217.66% YoY), and the FY2025 full-year result was -$3.0 million, down 162.71% from the prior year.
• Change in Account Payables for Q2 2023 stood at -$6.7 million, down from $9.7 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $26.2 million in Q1 2022 and bottomed at -$15.6 million in Q2 2022.
• The 4-year median for Change in Account Payables is $516000.0 (2021), against an average of -$525363.6.
• Peak annual rise in Change in Account Payables reached 4987.21% in 2022, while the deepest fall reached 2912.4% in 2022.
• A 4-year view of Change in Account Payables shows it stood at $4.3 million in 2020, then slumped by 87.87% to $524000.0 in 2021, then sank by 2912.4% to -$14.7 million in 2022, then jumped by 54.63% to -$6.7 million in 2023.
• The last three Change in Account Payables figures came in at -$6.7 million (Q2 2023), $9.7 million (Q1 2023), and -$14.7 million (Q4 2022), per Business Quant data.

Peer Comparison